James Munday, PhD
Science Lead Immunology & Immunotoxicology 

Harrogate, United Kingdom
It is an exciting time to work in this field—especially at Labcorp Drug Development. There are a variety of scientific challenges where our team is playing an active role in finding the solutions. I am fortunate to be surrounded by an amazing team who on a daily basis help meet the challenges of bringing new therapeutics to the market. It is motivating to work with some of the industry’s finest in a truly innovative environment.

During my time with Labcorp Drug Development, I’ve grown my knowledge while supporting Immunology and Immunotoxicology (I&I) drug development programs and gained exposure to several areas of drug development. One of the favourite parts of my job is playing an active role in industry bodies such as the European Bioanalysis Forum (EBF), European Immunogenicity Platform (EIP) and the European Medicines Agency (EMA). In these forums I have been able to work with thought leaders and Labcorp Drug Development colleagues to seek alignment on a broad array of I&I topics. We have focused recently on building inter-department collaboration for driving best practices across a variety of disciplines for immunogenicity assessment.

Before joining Labcorp Drug Development 8 years ago, I researched and worked in a variety of roles within the academic and pharmaceutical space—specializing in immunology. I obtained my doctorate at the University of Oxford where I did research in the field of molecular and cellular immunology. Throughout my studies, I authored several publications on a family of cell adhesion molecules known as Siglecs (Sialic acid binding immunoglobulin like lectins). After completion of my doctorate, I continued my academic career as a postdoctoral scientist at the Mount Sinai School of Medicine in New York. There, I focused on early haematopoiesis and vasculogenesis in embryonic stem cells. After completing my role at Mount Sinai, I gained my first position in the pharmaceutical industry as a Senior Scientist at Celltech/UCB in the Assay Technologies group. My role was to support the development and implementation of assays that assessed the potency and efficacy of compounds in-vivo for therapies targeting autoimmune disease. From there I moved to Quotient Bioresearch, where I worked on a diverse range of bioanalytical-based projects and biomedical testing for external pharmaceutical clients.

Back to Immunotoxicology page

Avoid scams. Stay safe in your job search.

Our recruiters only use emails that end in @labcorp.com or @agents.icims.com. Our recruiters will NOT request your personal information (social security number, birth certificate, banking passwords, driver’s license number or passport) and do NOT ask you to make any deposits or purchases. When in doubt, double-check the email address, search the drugdevelopmentcareers.labcorp.com site for our jobs and only apply via our online system. ​​​​​​​